Sensorion
ISIN: FR0012596468 | Ticker: ALSEN | LEI: 969500P0W8XJ9CGZDP97
Country: France
Sensorion’s mission is to offer innovative therapeutic solutions providing long-term improvements to people living with, or at risk of, inner ear disorders. Sensorion’s portfolio of solutions to unmet medical and social needs in inner ear disorders rests on three pillars – Restore, Treat, Prevent.
Restore
We aim to restore hearing by treating genetic diseases previously regarded as untreatable.
Treat
We aim to treat hearing disorders through innovative small molecule therapeutic solutions.
Prevent
We aim to prevent non-genetic hearing loss (e.g drug or surgery-related) through targeted therapeutic programs.
2009
Served areaWorldwide
Headcount34
Headquarters375 Rue du Professeur Joseph Blayac, 34080 Montpellier – France
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 08.08.23 | None | Other | Other | EUR 12,999,999.88 |
| 03.08.23 | None | Other | Other | EUR 7,000,000.00 |
FR0012596468
LEI969500P0W8XJ9CGZDP97
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.